Failure time analysis in malignant hematologic disorders
Oguma, S.
Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 84: 92-100
1990
ISSN/ISBN: 0047-1860 PMID: 2362367 Document Number: 355056
Document emailed within 1 workday
Related Documents
Blumberg, A. 1982: Hematologic disorders in renal failure Therapeutische Umschau. Revue Therapeutique 39(5): 379-383Lisker, R. 1987: Cytogenetic findings in malignant hematologic disorders Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 39(2): 187-196
Conley, C.L. 1981: Immunologic precursors of autoimmune hematologic disorders. Autoimmune hematologic disorders. Autoimmune hemolytic anemia and thrombocytopenic purpura Johns Hopkins Medical Journal 149(3): 101-109
Bakchine, H.; Brauner, R.; Thibaud, E.; Rappaport, R.; Flamant, F.; Griscelli, C.; Lemerle, J.; Schaison, G.; Schweisguth, O.; Zucker, J.M. 1986: Chemotherapy and ovarian function. Retrospective analysis in 17 girls treated for malignant tumor or hematologic disease Archives Francaises de Pediatrie 43(8): 611-616
Ohara, T.; Itoh, K. 2002: Revisited univariate delta check method for hematologic laboratories (I)--Usefulness for detection of specimen mix-up in patients with hematologic disorders Rinsho Byori. Japanese Journal of Clinical Pathology 50(11): 1072-1075
Smejcová, I.; Hauser, F.; Macholda, F.; Voslárová, Z. 1991: Analysis of mortality time series in malignant lung tumors and its future trends Sbornik Lekarsky 93(3-4): 95-100
Haese, A.; Huland, E.; Graefen, M.; Huland, H. 1999: Supersensitive PSA-analysis after radical prostatectomy: a powerful tool to reduce the time gap between surgery and evidence of biochemical failure Anticancer Research 19(4a): 2641-2644
Théon, A.P.; Rodriguez, C.; Madewell, B.R. 1997: Analysis of prognostic factors and patterns of failure in dogs with malignant oral tumors treated with megavoltage irradiation Journal of the American Veterinary Medical Association 210(6): 778-784
Müller-Wiefel, D.E. 1980: Hematologic changes in chronic kidney failure Deutsche Medizinische Wochenschrift 105(8): 277-278
Bertrand, A. 1972: Hematologic disorders due to thiamphenicol La Nouvelle Presse Medicale 1(3): 196-197
Steruská, M. 1989: Interferon alpha in the treatment of malignant hematologic diseases Vnitrni Lekarstvi 35(12): 1164-1170
Libánský, J. 1978: Secondary infections in malignant hematologic diseases and tumors Vnitrni Lekarstvi 24(5): 475-486
Aractingi, S.; Mansouri, S. 1997: Cutaneous manifestations related to malignant hematologic diseases Presse Medicale 26(14): 678-683
Sinkó, J.; Csomor, J.; Nikolova, R. 1998: Invasive fungal infection in malignant hematologic diseases Orvosi Hetilap 139(8): 409-412
Patel, A.R.; Shah, P.C.; Vohra, R.M.; Hart, W.L.; Shah, J.R. 1980: Serum ferritin levels in hematologic malignant neoplasms Archives of Pathology and Laboratory Medicine 104(10): 509-512
Johnsen, H.E.; Birgens, H.; Hansen, N.E. 1991: Autologous bone marrow transplantation in malignant hematologic diseases Ugeskrift for Laeger 153(25): 1790-1793
Arevalo, C.; Gajardo, M.; León, A.; Espinoza, E.; Marín, F. 1989: Relationship between various erythrocyte antigens and hematologic disorders Revista Medica de Chile 117(11): 1221-1226
Chong, L.L.; Wang, Y.C.; Hsueh, S.C. 1985: Aspiration cytology of the spleen in hematologic disorders Journal of the Formosan Medical Association 84(12): 1323-1333
Yamada, H.; Nagura, E. 1993: Dyskinesias as neurologic complications of hematologic disorders Nihon Rinsho. Japanese Journal of Clinical Medicine 51(11): 2913-2918
Densmore, J.J. 2008: Inherited and acquired hematologic disorders in athletes Clinical Advances in Hematology and Oncology: H&o 6(2): 111-112